Skip to main content
SpringerLink
Log in

Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie

  • Conference paper
Therapieresistenz unter Antidepressiva-Behandlung

Part of the book series: Tropon-Symposium ((BAYERZNS,volume 5))

Zusammenfassung

Für dieses Referat habe ich die umfangreiche Literatur der letzten 5 Jahre zum Thema aufgearbeitet. Als ich dann das daraus extrahierte Schema mit einem Stufenschema verglich, das ich vor 10 Jahren publiziert hatte, stellte ich zu meiner Überraschung fest, daß beide Schemata weitgehend übereinstimmten. Darauf habe ich mich gefragt, warum ein sachlich offenbar zutreffendes Schema so wenig die klinische Wirklichkeit beeinflußt hat, nicht einmal die eigene Klinik und auch nicht immer eigene therapeutische Entscheidungen. Die Antwort lautet: Bei der unübersehbaren Vielfalt der Entscheidungsmöglichkeiten kann die therapeutische Entscheidung im Einzelfall nur dann auf eine rationalere Basis gestellt werden, wenn sie einer regelmäßigen und standardisierten Response-Kontrolle folgt und jede - natürlich jederzeit mögliche - Abweichung vom Standard explizit begründet wird. Diesen beiden Prinzipien gegenüber sind alle Details und auch Unterschiede zwischen den zahlreichen Stufenschemata zur Depressionsbehandlung zweitrangig.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abrams R (1988) A Reply to Andrade and Gangadhar (When is an ECT responder an ECT responder?). Convulsive Ther 5:191–194

    Google Scholar 

  • Amsterdam JD, Berwish NJ (1989) High dose tranylcypromine therapy for refractory depression. Pharmacopsychiatry 22:21–25

    Article  PubMed  CAS  Google Scholar 

  • Angst J, Theobald W, Bleuler M, Kuhn R (1970) Tofranil (Imipramine). Stampfli, Bern

    Google Scholar 

  • Antonuccio DO, Akins WT, Chatham PM, Monagin JA, Tearnan BH, Ziegler BL (1984) An exploratory study: the psychoeducational group treatment of drug-refractory unipolar depression. J Behav Ther Exp Psychiatry 15:309–313

    Article  PubMed  CAS  Google Scholar 

  • Aronson TA, Shukla S (1989) Long-term continuation antidepressant treatment: A comparison study. J Clin Psychiat 50:285–289

    CAS  Google Scholar 

  • Ayd FJ (1985) Psychostimulant therapy for depressed medically ill patients. Psychiatric Annals 7:462–465

    Google Scholar 

  • Baldessarini RJ (1989) Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatr 50:117–126

    CAS  Google Scholar 

  • Barker WA, Scott J, Eccleston D (1987) The Newcastle chronic depression study: results of a treatment regime. Int Clin Psychopharmacol 2:261–272

    Article  PubMed  CAS  Google Scholar 

  • Benkert O, Hippius H (1986) Psychiatrische Pharmakotherapie, 4 Aufl Springer, Berlin Heidelberg New York

    Google Scholar 

  • Blazer D (1988) New concepts in the diagnosis and management of depression. Compr Ther 14:56–60

    PubMed  CAS  Google Scholar 

  • Boman B (1988) L-tryptophan: a rational anti-depressant and natural hypnotic? Aust NZJ Psychiat 22:83–97

    Article  CAS  Google Scholar 

  • Charney DS, Price LH, Heninger GR (1986) Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action. Arch Gen Psychiat 43:1155–1161

    Article  PubMed  CAS  Google Scholar 

  • Coffey CE, Figiel GS, Djang WT, Cress M, Saunders WB, Weiner RD (1988) Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiat 24:143–161

    Article  PubMed  CAS  Google Scholar 

  • Colloque international (1986) Les depressions resistantes aux traitements antidepresseurs. Encephale 12:187–262

    Google Scholar 

  • De la Fuente JR, Berlanga C, Leon-Andrade C (1986) Mania induced by tricyclic-MAOI combination therapy in bipolar treatment-resistant disorder: case reports. J Clin Psychiat 47:40–41

    Google Scholar 

  • Delgado PL, Price LH, Charney DS, Heninger GR (1988) Efficacy of fluvoxamine in treatment-refractory depression. J Affective Disord 15:55–60

    Article  CAS  Google Scholar 

  • De Montigny C, Elie R, Caille G (1985) Rapid response to the addition of lithium in iprindole-resis- tant unipolar depression: a pilot study. Am J Psychiat 142:220–223

    PubMed  Google Scholar 

  • Des Lauriers A, Baruch P, Vindreau C, Jouvent R, Wildloecher D (1987) Depressions resistant aux traitements antidepresseurs tricycliques et hypothyroide. Ann Med Interne 138:119–122

    Google Scholar 

  • Dessauer M, Goetze U, Toelle R (1985) Periodic sleep deprivation in drug-refractory depression. Neuropsychobiology 13:111–116

    Article  PubMed  CAS  Google Scholar 

  • Dilsaver SC, Greden JF (1983) Antidepressant withdrawal syndromes: evidence for supersensitivity of cholinergic systems as an etiologic factor. J Clin Psychiat 3:330

    CAS  Google Scholar 

  • Dilsaver SC, Kronfol Z, Sackellares JC, Greden JF (1983) Antidepressant withdrawal syndroms: evidence supporting the cholinergic overdrive hypothesis. J Clin Psychiat 3:157–164

    CAS  Google Scholar 

  • Donaldson SR (1989) Tolerance to phenelzine and subsequent refractory depression: three cases. J Clin Psychiat 50:33–35

    CAS  Google Scholar 

  • Evans DL, Strawn STK, Haggerty JJ, Garbutt JC et al. (1986) Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine. J Clin Psychiat 47:521–522

    CAS  Google Scholar 

  • Faust V, Hole G, Wolfersdorf M (1986) Die sogenannte therapieresistente Depression. Ursachen und Behandlungsmöglichkeiten. Fortschr Med 104:465–468

    PubMed  CAS  Google Scholar 

  • Feighner JP, Herbstein J, Damlouji N (1985) Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. J Clin Psychiat 46:206–209

    CAS  Google Scholar 

  • Gabbard GO (1988) A contemporary perspective on psychoanalytically informed hospital treatment. Hosp Community Psychiat 39:1291–1295

    CAS  Google Scholar 

  • Georgotas A, Friedman E, McCarthy M et al. (1987) Resistant geriatric depression and therapeutic response to monoamine oxidase inhibitors. Biol Psychiat 18:195–205

    Google Scholar 

  • Gitlin MJ, Weiner H, Fairbanks L, Hershman JM, Friedfeld N (1987) Failure of T3 to potentiate tricyclic antidepressant response. J Affective Disord 13:267–272

    Article  CAS  Google Scholar 

  • Guze BH, Baxter LR Jr, Rego J (1987) Refractory depression treated with high doses of monoamine oxidase inhibitor. J Clin Psychiat 48:31–32

    CAS  Google Scholar 

  • Hale AS, Procter AW, Bridges PK (1987) Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. Br J Psychiat 151:213–217

    Article  CAS  Google Scholar 

  • Haug HJ, Fähndrich E (1986) Problems in defining response in therapy studies. Pharmacopsychiat 19:170–171

    Article  Google Scholar 

  • Heimann H (1974) Therapy resistant depressions: Symptoms and syndromes. Pharmakopsychiat 7:139–144

    Article  CAS  Google Scholar 

  • Heimann H (1987) Die chronische Depression. Vortrag auf der Wanderversammlung der südwestdeutschen Neurologen und Psychiater

    Google Scholar 

  • Heimchen H (1974) Symptomatology of therapy-resistant depressions. Pharmakopsychiat 7:967–980

    Google Scholar 

  • Heimchen H (1979) Current trends of research on antidepressive treatment and prophylaxis. Com- prehens Psychiat 20:201–214

    Article  Google Scholar 

  • Horenstein M (1986) Place des therapies cognitivo-comportementales dans les depressions resistantes. Encephale 12:231–236

    PubMed  Google Scholar 

  • Jansson L, Ost LG (1986) Kognitiv-beteendeterapi vid depression: Med eller utan antidepressiva far- maka? Scand J Beh Therapy 15:95–103

    Article  Google Scholar 

  • Jefferson JW (1989) Lithium: a therapeutic magic wand. J Clin Psychiat 50:81–86

    CAS  Google Scholar 

  • Johnson GF (1987) Lithium in depression: a review of the antidepressant and prophylactic effects of lithium. Aust NZJ Psychiat 21:356–365

    Article  CAS  Google Scholar 

  • Katona CL (1988) Lithium augmentation in refractory depression. Psychiat Dev 6:153–171

    CAS  Google Scholar 

  • Kielholz P (1986) Treatment for therapy-resistant depression. Psychopathology 19:194–200

    Article  PubMed  Google Scholar 

  • Kuhs H, Toelle R (1986) Schlafentzug (Wachtherapie) als Antidepressivum. Fortschr Neurol Psychiat 54:341–355

    Article  PubMed  CAS  Google Scholar 

  • Kupfer DJ, Freedman DX (1986) Treatment for depression: ”Standard” clinical practice as an unexamined topic. Arch Gen Psychiat 43:509–511

    Article  PubMed  CAS  Google Scholar 

  • Larsen JK (1988) MAO inhibitors: pharmacodynamic aspects and clinical implications. Acta Psychiat Scand 345:74–80

    CAS  Google Scholar 

  • Larsen JK, Rafaelson OJ (1980) Long-term treatment of depression with isocarboxazide. Acta Psychiatr Scand 60:456–463

    Article  Google Scholar 

  • Laux G (1983) Die sogenannte therapieresistente Depression. In: Faust V, Hole G (eds.): Depressionen. Hippokrates, Stuttgart

    Google Scholar 

  • Laux G (1986) Chronifizierte Depressionen. Eine klinische Verlaufsuntersuchung unter Berücksichtigung typologischer, therapeutischer und prognostischer Aspekte. PY, p 142

    Google Scholar 

  • Lazarus LW, Groves L, Gierl B, Pandey G et al. (1986) Efficacy of phenelzine in geriatric depression. Biol Psychiat 21:699–701

    Article  PubMed  CAS  Google Scholar 

  • Leonhard BE (1988) Biochemical aspects of therapy-resistant depression. Brit J Psychiat 152:453–459

    Article  Google Scholar 

  • Levine S (1986) The management of resistant depression. Acta Psychiat 86:141–151

    CAS  Google Scholar 

  • Linden M, Schüssler G (1986) Compliance and treatment outcome of antidepressant therapy in private psychiatric practice. Pharmakopsychiat 19:429–433

    Article  Google Scholar 

  • Linet LS (1989) Treatment of a refractory depression with a combination of fluoxetine and δ-amphetamine (letter). Am J Psychiat 146:803–804

    PubMed  CAS  Google Scholar 

  • Lydiard RB (1985) Tricyclic-resistant depression: treatment resistance or inadequate treatment? J Clin Psychiat 46:412–417

    CAS  Google Scholar 

  • MacEwan GW, Remick RA (1988) Treatment resistant depression: a clinical perspective. Canad J Psychiat 33:788–792

    CAS  Google Scholar 

  • MacGrath PJ, Stewart JW, Harrison W, Quitkin FM (1987) Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant. Psychol Bull 23:169–172

    Google Scholar 

  • Madakasira S (1986) Carbamazepine for treatment-resistant depressions? (letter). Am J Psychiat 143:1310–1311

    PubMed  CAS  Google Scholar 

  • Miller IW, Bishop STB, Norman WH, Keitner GI (1985) Cognitive/behavioural therapy and pharmacotherapy with chronic, drug-refractory depressed in patients: a note of optimism. Behav Psychotherapy 13:320–327

    Article  Google Scholar 

  • Möller H-J, Kissling W, Herberger B, Kuss HJ (1984) Kontrollierte Studie über die möglichen Vorteile einer Kombinationstherapie mit Clomipramin und Haloperidol bei endogen Depressiven. Pharmakopsychiat 17:29–33

    Article  Google Scholar 

  • Möller H-J, Kissling W, Herberger B, Binz U, Wendt G, Spahn H (1986) Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression. Pharmakopsychiat 19:362–364

    Article  Google Scholar 

  • Nelson JC, Mazure CM (1986) Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiat 143:363–366

    PubMed  CAS  Google Scholar 

  • Nolen WA, van de Putte JJ, Dijken WA, Kamp JS, Lansjaar BA, Kramer HJ, Haffmanns J (1988) Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine. Acta Psychiatr Scand 78:668–675/676–683

    Article  PubMed  CAS  Google Scholar 

  • Norman TR, Sartor DM, McIntyre IM (1988) Clinical and experimental studies on the potentiation of antidepressant drugs by thyroid hormones. Med Sci Research 16:545–550

    CAS  Google Scholar 

  • Olivier-Martin R (1986) Facteurs psychologiques, observances et resistance aux traitements antidepresseurs. Encephale 12:197–203

    PubMed  Google Scholar 

  • Ostow M (1985) Pharmacologic treatment of manic and depressive illness. Compr Ther 11:24–30

    PubMed  CAS  Google Scholar 

  • Panteleeva GP, Borisova KE, Mikhailova NM (1984) Lechenie noverilom bol’nykh s terapevticheski rezistentynmi depressiiami. ZH Nevropat Psikhiat 84:1221–1226

    CAS  Google Scholar 

  • Pare CMB (1985) The present status of monoamine oxidase inhibitors. Br J Psychiat 146:576–584

    Article  CAS  Google Scholar 

  • Pichot P (1974) Therapy resistant depressions. Methodological problems. Pharmakopsychiat 7:80–84

    Article  CAS  Google Scholar 

  • Pöldinger W (1985) Die biologisch-pharmakologisch orientierten Behandlungsmethode der Depressionen unter besonderer Berücksichtigung der Anliegen der Praxis. Wien Klin Wschr 97:165–175

    PubMed  Google Scholar 

  • Pöldinger W, Dirnhofer-Bertolini E (1989) Die Behandlung schwerer therapieresistenter Depressionen mit Infusionen von Antidepressiva. Schweiz Rundsch Med Prax 78:188–190

    PubMed  Google Scholar 

  • Pomara N, Gershon S (1984) Treatment-resistant depression in an elderly patient with pancreatic carcinoma: case report. J Clin Psychiat 45:439–440

    CAS  Google Scholar 

  • Price LH, Charney DS, Heninger GR (1985) Efficacy of lithium-tranylcypromine treatment in refractory depression. Am J Psychiat 142:619–623

    PubMed  CAS  Google Scholar 

  • Price LH, Charney DS, Heninger GR (1986) Variability of response to lithium augmentation in refractory depression. Am J Psychiat 143:1387–1392

    PubMed  CAS  Google Scholar 

  • Quitkin FM (1985) The importance of dosage in prescribing antidepressants. Br J Psychiat 147:593–597

    Article  CAS  Google Scholar 

  • Quitkin FM, Rabkin JG, Ross D, McGrath PJ (1984) Duration of antidepressant drug treatment. Arch Gen Psychiat 41:238–245

    Article  PubMed  CAS  Google Scholar 

  • Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wagner SG (1988) Phenelzine vs impramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiat 145:306–311

    PubMed  CAS  Google Scholar 

  • Raskind M (1984) Electroconvulsive therapy in the elderly. J Am Geriatrics Soc 23:177–178

    Google Scholar 

  • Robinson DS, Nies A, Ravaris CL, Ives IO, Bartlett D (1978) Clinical pharmacology of Phenelzine. Arch Gen Psychiat 35:629–635

    Article  PubMed  CAS  Google Scholar 

  • Sauer H, Lauter H (1987 a) Elektrokrampftherapie I Wirksamkeit, Nebenwirkungen. Nervenarzt 58:201–209

    PubMed  CAS  Google Scholar 

  • Sauer H, Lauter H (1987b) Elektrokrampftherapie II Indikationen, Kontraindikationen und therapeutische Technik. Nervenarzt 58:210–218

    PubMed  CAS  Google Scholar 

  • Schatzberg AF (1988) Depressive disorders. In: Tupin J et al (eds) Handbook of clinical psychopharmacology. Aronson, Northvale NJ 49–71

    Google Scholar 

  • Schmauß M, Meller I (1989) Die “therapieresistente” Depression - Ursachen und Behandlungsmöglichkeiten. Psychiat Prax 16:101–108

    Google Scholar 

  • Schmauß M, Kapfhammer HP, Meyr P, Hoff P (1988) Combined MAO-inhibitor and tri-(tetra)cyclic antidepressant treatment in therapy resistant depression. Prog Neuropsychopharmacol 12:523–532

    Article  Google Scholar 

  • Schmauß M, Laakmann G, Dieterle D (1988) Effects of alpha 2-receptor-blockade in addition to tricyclic antidepressants in therapy-resistant depression. J Clin Psychopharmacol 8:108–111

    Article  PubMed  Google Scholar 

  • Schoepf J (1989) Lithiumzugabe zu Thymoleptika als Behandlung therapieresistenter Depressionen. Nervenarzt 60:200–205

    Google Scholar 

  • Schrader GD, Levien HE (1985) Response to sequential administration of clomipramine and lithium carbonate in treatment-resistant depression. Br J Psychiat 147:573–575

    Article  CAS  Google Scholar 

  • Shapira B, Oppenheim G, Zoher J, Segal M, Malach D, Belmaker RH (1985) Lack of efficacy of estrogen supplementation in resistant female depressives. Biol Psychiat 20:576–579

    Article  PubMed  CAS  Google Scholar 

  • Shapira B, Kindler S, Lerer B (1988) Medication outcome in ECT-resistant depression. Convulsive Ther 4:192–198

    Google Scholar 

  • Shaw DM (1988) Pharmacological management of treatment-resistant depression. Psychopharmacol Ser 5:118–129

    PubMed  CAS  Google Scholar 

  • Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, Perel JM, Rossi AJ, Soloff PH (1985) The pharmacological treatment of delusional depression. Am J Psychiat 142:430–436

    PubMed  CAS  Google Scholar 

  • Targum SD, Greenberg RD, Harmon RL, Kessler K, Salerian AJ, Fram DH (1984) Thyroid hormone and the TRH stimulant test in refractory depression. J Clin Psychiat 45:345–346

    CAS  Google Scholar 

  • Thase ME, Kupfer DJ (1985) Strategies for tricyclic-resistant depressions. Abstract IV World Congress of Biological Psychiatry, Philadelphia, 271

    Google Scholar 

  • Tollefson GD (1983) Monoamine oxidase inhibitors: a review. J Clin Psychiat 44:280–288

    CAS  Google Scholar 

  • Vandel B, Vandel S (1986) Facteurs pharmacocinetiques et resistance aux traitements antidepresseurs. Encephale 12:217–222

    PubMed  CAS  Google Scholar 

  • Vinar O (1984) Tranylcypromine in treatment of resistant depression. Activ Nerv Sup 26:239–241

    Google Scholar 

  • Wager SG, Klein DF (1988) Drug therapy strategies for treatment-resistant depression. Psychopharm Bull 24:69–74

    CAS  Google Scholar 

  • Waldmeier P (1983) 4.3 Neurobiochemische Wirkungen antidepressiver Therapie. In: Langer G, Heiman H (Hrsg) Psychopharmaka. Springer, Wien New York

    Google Scholar 

  • White K, Simpson G (1985) Should the use of MAO inhibitors be abandoned. Integr Psychiatry 3:34–45

    Google Scholar 

  • Woggon B (1987) Pharmakotherapie affektiver Psychosen. In: Kisker KP, Lauter H, Meyers JE, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart 5. Affektive Psychosen. Springer, Berlin Heidelberg New York, S 273–325

    Google Scholar 

  • Woggon B, Baumann U (1983) Multimethodological approach in psychiatric predictor research. Pharmacopsychiat 16:175–178

    Article  CAS  Google Scholar 

  • Zimmer FT (1989) Verhaltenstherapie und Antidepressiva bei der Behandlung von Depressionen. In: Hand I, Wittchen HU (Hrsg) Verhaltenstherapie in der Medizin. Springer, Berlin Heidelberg New York London Paris Tokyo Hongkong, S 62–81

    Chapter  Google Scholar 

  • Zisook S (1985) A clinical overview of monoamine oxidase inhibitors. Psychosomatics 26:240–251

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Helmchen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrie, Universitäts-Nervenklinik, Sigmund-Freud-Straße 25, D-5300, Bonn 1, Deutschland

    Hans-Jürgen Möller

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Helmchen, H. (1990). Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Möller, HJ. (eds) Therapieresistenz unter Antidepressiva-Behandlung. Tropon-Symposium, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84236-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84236-8_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52765-7

  • Online ISBN: 978-3-642-84236-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation